{"id":"577a8b45-06e2-45d0-afb6-b8e7d9fd6dda","kind":"companies","code":"UB-C9904","name":"Yiyuan Biotechnology","nameBasis":"transliterated","summary":"Developer of embodied intelligent medical devices.","description":"Developer of embodied intelligent medical devices.","country":"China","category":null,"originalName":"翌远生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T00:00:00.000Z","englishUpdatedAt":"2026-10-18T08:52:12.006Z","reviewedAt":"2026-10-18T08:52:12.006Z","snapshotAt":"2026-10-17T04:56:34.702Z","sourceHash":"0af23c13f34af07754098969e4eb2206eaf3f38618ed420db5d732181f59c37c","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"具身智能医疗器械研发商","sources":[],"related":[{"id":"45f3cced-d089-454b-b5df-da62723577a1","kind":"people","code":"UB-P2110","name":"Ding Jianü","nameBasis":"transliterated","summary":"Legal Representative and Chair and Manager","description":"","country":null,"category":null,"originalName":"丁佳女","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:12.921Z","englishUpdatedAt":"2026-10-15T18:37:37.109Z","reviewedAt":"2026-10-15T18:37:37.109Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2ece73964c11ff889c2739bd3ccdb09158ca9abbacbdf14fbb639501cd77bb93","companyId":"577a8b45-06e2-45d0-afb6-b8e7d9fd6dda","foundedYear":null,"logoUrl":null,"path":"/people/ding-jianu"},{"id":"d150b130-4acf-46a5-b29c-b7197a55abe9","kind":"news","code":"d150b130-4acf-46a5-b29c-b7197a55abe9","name":"Yiyuan Biotechnology completes equity financing","nameBasis":"translated-title","summary":"On 2026-08-31, according to Xiniu Data, Yiyuan Biotechnology completed equity financing for an undisclosed amount. Investors were Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership). The company is a developer of embodied intelligent medical devices.","description":"","country":null,"category":null,"originalName":"翌远生物完成股权投资融资","eventDate":"2026-08-31T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T16:32:29.704Z","englishUpdatedAt":"2026-10-15T20:50:21.947Z","reviewedAt":"2026-10-15T20:50:21.947Z","snapshotAt":"2026-10-15T16:47:01.523Z","sourceHash":"39f20749621e255ed6713c2059a53ee4b6aface06dd54585365f17f6c9d3c8b5","companyId":"577a8b45-06e2-45d0-afb6-b8e7d9fd6dda","foundedYear":null,"logoUrl":null,"path":"/news/d150b130-4acf-46a5-b29c-b7197a55abe9"},{"id":"212c2c33-bde9-4f07-ab7d-ece6d2b80cd8","kind":"institutions","code":"UB-I7209","name":"昆山天使二期投资基金合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":null,"category":null,"originalName":"昆山天使二期投资基金合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.306Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"8d558f103d810a8ff956694a34889475e888533da5152c1837eab327f18a4cb8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership)","path":"/institutions/kunshantianshi-phase-two-investment-fund-partnership-limited-partnership"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"d150b130-4acf-46a5-b29c-b7197a55abe9","date":"2026-08-31T00:00:00.000Z","round":"Equity","amountText":"金额未知","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":null,"institutions":[{"id":"212c2c33-bde9-4f07-ab7d-ece6d2b80cd8","kind":"institutions","code":"UB-I7209","name":"昆山天使二期投资基金合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":null,"category":null,"originalName":"昆山天使二期投资基金合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.306Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"8d558f103d810a8ff956694a34889475e888533da5152c1837eab327f18a4cb8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership)","path":"/institutions/kunshantianshi-phase-two-investment-fund-partnership-limited-partnership"}],"newsUrl":null,"evidence":{"headline":"Yiyuan Biotechnology completes equity financing","brief":"On 2026-08-31, according to Xiniu Data, Yiyuan Biotechnology completed equity financing for an undisclosed amount. Investors were Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership). The company is a developer of embodied intelligent medical devices.","basis":"translated-source-brief","newsPath":"/news/d150b130-4acf-46a5-b29c-b7197a55abe9","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"d150b130-4acf-46a5-b29c-b7197a55abe9","date":"2026-08-31T00:00:00.000Z","round":"Equity","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":null,"institutions":[{"id":"212c2c33-bde9-4f07-ab7d-ece6d2b80cd8","kind":"institutions","code":"UB-I7209","name":"昆山天使二期投资基金合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":null,"category":null,"originalName":"昆山天使二期投资基金合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.306Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"8d558f103d810a8ff956694a34889475e888533da5152c1837eab327f18a4cb8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership)","path":"/institutions/kunshantianshi-phase-two-investment-fund-partnership-limited-partnership"}],"newsUrl":null,"evidence":{"headline":"Yiyuan Biotechnology completes equity financing","brief":"On 2026-08-31, according to Xiniu Data, Yiyuan Biotechnology completed equity financing for an undisclosed amount. Investors were Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership). The company is a developer of embodied intelligent medical devices.","basis":"translated-source-brief","newsPath":"/news/d150b130-4acf-46a5-b29c-b7197a55abe9","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"d150b130-4acf-46a5-b29c-b7197a55abe9","kind":"funding","eventDate":"2026-08-31T00:00:00.000Z","revenueDate":null,"round":"股权投资","amountText":"金额未知","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":null,"newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"212c2c33-bde9-4f07-ab7d-ece6d2b80cd8","kind":"institutions","code":"UB-I7209","name":"昆山天使二期投资基金合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":null,"category":null,"originalName":"昆山天使二期投资基金合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.306Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"8d558f103d810a8ff956694a34889475e888533da5152c1837eab327f18a4cb8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership)","path":"/institutions/kunshantianshi-phase-two-investment-fund-partnership-limited-partnership"}],"roundName":"Equity","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"45f3cced-d089-454b-b5df-da62723577a1","kind":"people","code":"UB-P2110","name":"Ding Jianü","nameBasis":"transliterated","summary":"Legal Representative and Chair and Manager","description":"","country":null,"category":null,"originalName":"丁佳女","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:12.921Z","englishUpdatedAt":"2026-10-15T18:37:37.109Z","reviewedAt":"2026-10-15T18:37:37.109Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2ece73964c11ff889c2739bd3ccdb09158ca9abbacbdf14fbb639501cd77bb93","companyId":"577a8b45-06e2-45d0-afb6-b8e7d9fd6dda","foundedYear":null,"logoUrl":null,"path":"/people/ding-jianu"}],"productsRelated":[],"investors":[{"id":"212c2c33-bde9-4f07-ab7d-ece6d2b80cd8","kind":"institutions","code":"UB-I7209","name":"昆山天使二期投资基金合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":null,"category":null,"originalName":"昆山天使二期投资基金合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.306Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"8d558f103d810a8ff956694a34889475e888533da5152c1837eab327f18a4cb8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership)","path":"/institutions/kunshantianshi-phase-two-investment-fund-partnership-limited-partnership"}],"path":"/companies/UB-C9904","structured":{"city":"Suzhou","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Yiyuan Biotechnology is a company headquartered in Suzhou, China.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C9904"}